Cambium Bio Limited
CMB
Rank in Stocks
#32547
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.31737816
Last synced: 2026-10-18
Market Cap
$9.34M
Change (1 day)
0.00%
Change (1 year)
5,917.33%
Country
AU
Trade Cambium Bio Limited (CMB)
Category
Healthcare
Market Capitalization of Cambium Bio Limited(CMB)
Market Cap: $9.34M
As of October 2026 Cambium Bio Limited has a market cap of $9.34M. This makes Cambium Bio Limited the world's 32547th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cambium Bio Limited from 2013 to 2026
CMB compared with Top 5 Most Popular stocks
